News

In the second part of our blog series, we explore how the ability to measure adherence can give pharmaceutical companies the wherewithal to drive revenue growth.

What can a pharmaceutical firm do to sustainably grow revenue and margins? Read the first article of our three-part blog series to find out more.

We are pleased to share some of our recent news with you. We hope we see you at BIO in Philadelphia in June and at Drug Delivery West in San Francisco in May.

Portal Instruments and Gerresheimer, a leading global partner in the pharma and healthcare industries is pleased to announce a joint talk to be given in Paris at the Pharmapack 2019 convention. The talk is titled New Meets Old: Challenges and Solutions with Developing a Custom Primary Container.

2018 has been a busy and exciting year for Portal Instruments as we continue to advance our connected, needle-free drug delivery device. As the year draws to a close, we would like to thank our team for their efforts and share with our friends and supporters all that we have accomplished.

On average, patients with a chronic illness only take about 1/2 the medication that they are prescribed.

Portal Instruments was recently selected as one of 10 hottest Medtech startups of 2018 by Medical Design & Outsourcing.

Portal Instruments recently participated in Mediaplanet USA’s Autoimmune Diseases campaign, where we united with industry leaders to increase awareness about the over 100 autoimmune diseases that plague millions of Americans today.

Dr. Ian Hunter, Hatsopolous Professor of Mechanical Engineering at MIT, and inventor of the underlying Portal needle-free technology, describes his journey from inception of the technology through different iterations of prototypes that eventually evolve into the handheld prototype that we have today.

Needle-free drug delivery devices have been around since the 1960s. However, most of these devices could only deliver a limited volume of medication, had limited ability to control injection depth, and were known to be loud and painful. These factors created barriers to their widespread adoption.